Inadequate treatment of dyslipidemia in people with type 2 diabetes: Quality assessment of diabetes care in a Danish County

Scandinavian Journal of Primary Health Care

Volumn 24, Issue 3, 2006, Pages 181-185

  Kristensen, Jette Kolding ^a   Lauritzen, Torsten ^a  

^a AARHUS UNIVERSITY   (Denmark)

Author keywords

Dyslipidemia; General practice; Quality assessment; Routine monitoring; Type 2 diabetes

Indexed keywords

ANTILIPEMIC AGENT; CHOLESTEROL; FIBRIC ACID DERIVATIVE; HEMOGLOBIN A1C; INSULIN; NICOTINIC ACID DERIVATIVE; ORAL ANTIDIABETIC AGENT;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; DENMARK; DISEASE DURATION; DYSLIPIDEMIA; FEMALE; HEART INFARCTION; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; NATIONAL HEALTH SERVICE; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT COMPLIANCE; REGISTER; STATISTICAL ANALYSIS;

ADULT; AGED; ANTILIPEMIC AGENTS; CHOLESTEROL; DENMARK; DIABETES MELLITUS, TYPE 2; DYSLIPIDEMIAS; FEMALE; HUMANS; MALE; MIDDLE AGED; QUALITY ASSURANCE, HEALTH CARE; REGISTRIES; TREATMENT OUTCOME;

EID: 33747670301     PISSN: 02813432     EISSN: 15027724     Source Type: Journal    
DOI: 10.1080/02813430600819710     Document Type: Article

References (20)

1. Uusitupa M, Siitonen O, Aro A, Pyörala K. Prevalence of coronary heart disease, left ventricular failure and hypertension in middle-aged newly diagnosed Type 2 (non-insulin-dependent) diabetic subjects. Diabetologia 1985;28:22-7.
2. Haffner SM, Lehto S, Rönnemaa T, Pyörala K, Laakso M. Mortality from coronary heart disease in subjects with Type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 1998;339:229-34.
3. Turner RC, Millns H, Neil HAW, Stratton IM, Manley SE, Matthews DR, Holman RR. Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom prospective diabetes study (UKPDS: 23). BMJ 1998;316:823-8.
4. Betteridge J, Colhoun H, Armitage J. Status report of lipid-lowering trials in diabetes. Curr Opin Lipidology 2000;11:621-6.
5. Heart Protection Study Collaborative Group.. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomized placebo-controlled trial. Lancet 2002;360:7-22.
6. Kanstrup H. Identification and management of dyslipidemia in clinical practice. Aarhus: Faculty of Health Sciences, University of Aarhus; 2001.
7. DSAM.. Type 2 diabetes i almen praksis: diagnose og Behandling. København: DSAM; 2002.
8. Olesen F, Lauritzen T. Do general practitioners want guidelines? Attitudes toward a county-based and a national college-based approach. Scand J Prim Health Care 1997;15:141-5.
9. Eliasson B, Cederholm J, Nilsson P, Gudbjornsdottir S. The gap between guidelines and reality: Type 2 diabetes in a national diabetes register 1996-2003. Diabet Med 2005;22:1420-6.
10. Hippisley-Cox J. Prevalence, care, and outcome for patients with diet controlled diabetes in general practice: Cross-sectional survey. Lancet 2004;363:423-8.
11. Kristensen JK, Sandbæk A, Lauritzen T, Lassen JF, Bro F. Use and validation of public data files for identification of the diabetic population in a Danish county. Dan Med Bull 2001;48:33-7.
12. Indenrigs- og Sundhedsministeriet. Handlingsplan om diabetes. København: Indenrigs- og Sundhedsministeriet; 2003.
13. Claudi T, Cooper J, Hausken Mf, Michaelsen T, Harboe K, Ingskog W. Risikointervensjon ved diabetes i allmennpraksis [Risk intervention in persons with diabetes mellitus in general practice]. Tidsskrift Nor Lægeforen 2004;124:1508-10.
14. Siann T, Duncan EM, Sullivan F. Area-wide diabetes care: The Lanarkshire experience with ordinary health care teams 1994-1997. Diabetic Med 1998;15:54-7.
15. Khunti K, Baker R, Rumsey M. Quality of care of patients with diabetes: Collation of data from multi-practice audits of diabetes in primary care. Fam Pract 1999;16:54-9.
16. Wandell P, Brorson B, Aaberg H. Diabetic patients in primary health care: Quality of care three years apart. Scand J Prim Health Care 1998;16:44-9.
17. Hansen LJ, Olivarius N, Siersma V, Drivsholm T, Andersen JS. Individualised treatment goals in diabetes care. Scand J Prim Health Care 2004;22:71-7.
18. Whincup PH, Emberson JR, Lennon L, Walker M, Papacosta O, Thomson A. Low prevalence of lipid-lowering drug use in older men with established coronary heart disease. Heart 2002;88:25-9.
19. Larsen J, Andersen M, Bjerrum L, Kragstrup J, Gram LF. Insufficient use of lipid-lowering drugs and measurement of serum cholesterol among patients with a history of myocardial infarction. J Cardiovascular Risk 2003;10:61-4.
20. Hellénius M, Nilsson P, Elofsson S, Johansson J, Krakau I. Reduction of high cholesterol levels associated with younger age and longer education in a primary health care programme for cardiovascular prevention. Scand J Prim Health Care 2005;23:75-81.